MODULATION OF TUMOR IMMUNITY
- 专利权人:
- MERCK SHARP & DOHME CORP
- 发明人:
- MERCK SHARP & DOHME CORP
- 申请号：
- GEAP2014014103
- 公开号：
- GEP20186905B
- 申请日:
- 2014.08.18
- 申请国别(地区):
- GE
- 年份:
- 2018
- 代理人:
- 摘要：
- There is provided usage of GITR agonist and PD-1 antagonist combination at tumor treatment.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- POTENTIATOR OF CANCER IMMUNITY CONTAINING RANKL ANTAGONIST
- COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS
- Combination therapy comprising OX40 binding agonists and PD-1 axis binding antagonists
- COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS
- COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS
